Novel Dental Cements (ALBO-MPCA) in Patients With Caries

Exclusion Criteria

• •Pregnancy and lactation 6 months before the study and during the study
• •Significant renal or hepatic impairment
• •Subject with a life expectancy of less than 6 months
• •Subjects with unacceptable occlusal interferences oral hygiene, and non-compliant patients
• •History of irreversible pulpal pain
• •Immature teeth
• •Non-restorable teeth
• •Teeth with active periodontal disease
• •History of any systemic disease
• •Concurrent medication with systemic steroids, antibiotics, analgetics, immunomodulatory drugs, or cytostatics
• •Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial
• •Participation in another research trial involving an investigational product in the past 12 weeks